NEVVI Medicare utilization intelligence

← back

COKER, WOODROWMD, MSPH NPI 1508028366 Clinician

Hematology-Oncology · CHARLESTON, SC

Specialty Hematology-Oncology — from billed Medicare claims
Trained MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE — medical school, self-reported to CMS
In practice about 18 years since medical school (class of 2008, self-reported to CMS)
Location CHARLESTON, SC · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 81 codes billed · 261,442 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
SOUTH CAROLINA ONCOLOGY ASSOC PA
2019–2026
MUSC COMMUNITY PHYSICIANS
2022
KERSHAW HOSPITAL LLC
2019–2021

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2011-06

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J9299 Injection, nivolumab, 1 mg
J0897 Injection, denosumab, 1 mg
J9271 Injection, pembrolizumab, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J0185 Injection, aprepitant, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9263 Injection, oxaliplatin, 0.5 mg
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J1627 Injection, granisetron, extended-release, 0.1 mg
J1449 Injection, eflapegrastim-xnst, 0.1 mg
A9585 Injection, gadobutrol, 0.1 ml
J9171 Injection, docetaxel, 1 mg
J9267 Injection, paclitaxel, 1 mg
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J1100 Injection, dexamethasone sodium phosphate, 1 mg
80048 Blood test, basic group of blood chemicals (calcium, total)
80076 Liver function blood test panel
Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
83615 Lactate dehydrogenase (enzyme) level
96372 Injection of drug or substance under skin or into muscle
82784 Gammaglobulin (immune system protein) measurement
96361 Infusion into a vein for hydration, each additional hour
J0640 Injection, leucovorin calcium, per 50 mg
85044 Red blood count, manual test
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
96413 Administration of chemotherapy into vein, 1 hour or less
82728 Ferritin (blood protein) level
J2469 Injection, palonosetron hcl, 25 mcg
83550 Iron binding capacity
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
83540 Iron level
82607 Cyanocobalamin (vitamin b-12) level
82746 Folic acid level, serum
J9190 Injection, fluorouracil, 500 mg
J9045 Injection, carboplatin, 50 mg
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
96375 Injection of additional new drug or substance into vein
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96417 Administration of additional new drug or substance into vein, 1 hour or less
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
71260 Ct scan of chest with contrast
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96415 Administration of chemotherapy into vein, each additional hour
74177 Ct scan of abdomen and pelvis with contrast
84443 Blood test, thyroid stimulating hormone (tsh)
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
84153 Psa (prostate specific antigen) measurement, total
82378 Carcinoembryonic antigen (cea) protein level
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
71250 Ct scan of chest without contrast
J7030 Infusion, normal saline solution , 1000 cc
J1200 Injection, diphenhydramine hcl, up to 50 mg
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
96411 Administration of additional new drug or substance into vein using push technique
96360 Infusion into a vein for hydration, 31-60 minutes
J3490 Unclassified drugs
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
J7060 5% dextrose/water (500 ml = 1 unit)
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
85610 Blood test, clotting time
74176 Ct scan of abdomen and pelvis without contrast
77080 Dxa bone density measurement of hip, pelvis, spine
70553 Mri scan of brain before and after contrast
83735 Magnesium level
96523 Irrigation of implanted venous access drug delivery device
74183 Mri scan of abdomen before and after contrast
71046 X-ray of chest, 2 views
81015 Urinalysis using microscope
G0008 Administration of influenza virus vaccine

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.